Clinical profile and fetal outcomes of liver disorders in pregnancy: a one-year retrospective study at a tertiary care centre

Hema J. Shobhane; Anushka Pandey

doi:10.18203/2320-1770.ijrcog20262096

Authors

Hema J. Shobhane Department of Obstetrics and Gynecology, Maharani Laxmi Bai Medical College, Jhansi, Uttar Pradesh, India
Anushka Pandey Department of Obstetrics and Gynecology, Maharani Laxmi Bai Medical College, Jhansi, Uttar Pradesh, India

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20262096

Keywords:

Liver disorders in pregnancy, HELLP, IHCP, Fetal outcome

Abstract

Background: Liver disorders in pregnancy are associated with significant maternal and perinatal morbidity and mortality. The spectrum includes pregnancy-specific conditions such as HELLP syndrome and intrahepatic cholestasis of pregnancy (IHCP), as well as coincidental hepatic diseases including viral hepatitis. Early diagnosis and timely management are critical for improving outcomes in affected mothers and neonates.

Methods: A retrospective observational study was conducted at Maharani Laxmi Bai Medical College and Hospital, Jhansi, from February 2025 to February 2026. A total of 200 pregnant women diagnosed with liver disorders were included. Data were collected from hospital records and analysed using the chi-square test with p<0.05 considered statistically significant.

Results: HELLP syndrome was the most common disorder (61%), followed by viral hepatitis (23%) and IHCP (16%). The mean patient age was 26.4±4.2 years. Intrauterine fetal demise (IUFD) was significantly higher in IHCP (21.9%) compared to HELLP (13.9%) and hepatitis (10.9%) (p=0.04). Preterm delivery (45.9%, p=0.01) and NICU admissions (51.6%, p=0.03) were significantly higher in HELLP syndrome. The difference in caesarean section rates across groups was not statistically significant (p=0.18).

Conclusions: HELLP syndrome is associated with significant maternal and neonatal morbidity, while IHCP demonstrates disproportionately higher fetal mortality despite lower prevalence. Viral hepatitis remains a clinically significant coincidental disorder. Early identification, multidisciplinary management, and timely obstetric intervention are essential to reduce adverse fetomaternal outcomes in pregnant women with liver disorders.

References

Williamson C, Geenes V. Intrahepatic cholestasis of pregnancy. Obstet Gynecol. 2014;124(1):120-33.

Westbrook RH, Dusheiko G, Williamson C. Pregnancy and liver disease. J Hepatol. 2016;64(4):933-45.

Lee NM, Brady CW. Liver disease in pregnancy. World J Gastroenterol. 2009;15(8):897-906.

Pathak B, Sheibani L, Lee RH. Cholestasis of pregnancy. Obstet Gynecol Clin North Am. 2010;37(2):269-82.

Sibai BM. Diagnosis, controversies, and management of the syndrome of hemolysis, elevated liver enzymes, and low platelet count. Obstet Gynecol. 2004;103(5):981-91.

Geenes V, Williamson C. Intrahepatic cholestasis of pregnancy. World J Gastroenterol. 2009;15(17):2049-66.

Arrese M, Reyes H. Intrahepatic cholestasis of pregnancy: a past and present riddle. Ann Hepatol. 2006;5(3):202-5.

Ovadia C, Seed PT, Sklavounos A, Geenes V, Di Ilio C, Chambers J, et al. Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers: results of aggregate and individual patient data meta-analyses. Lancet. 2019;393(10174):899-909.

Patra S, Kumar A, Trivedi SS, Puri M, Sarin SK. Maternal and fetal outcomes in pregnant women with acute hepatitis E virus infection. Ann Intern Med. 2007;147(1):28-33.

Bzowej NH. Hepatitis B therapy in pregnancy. Curr Hepat Rep. 2010;9(4):197-204.

Ahmed KT, Almashhrawi AA, Rahman RN, Hammoud GM, Ibdah JA. Liver diseases in pregnancy: diseases unique to pregnancy. World J Gastroenterol. 2013;19(43):7639-46.

Hay JE. Liver disease in pregnancy. Hepatology. 2008;47(3):1067-76.

Goel A, Jamwal KD, Ramachandran A, Balasubramanian KA, Eapen CE. Pregnancyrelated liver disorders. J Clin Exp Hepatol. 2014;4(2):151-62.

Wadhwa L, Sarin SK, Govila A. Maternal outcome of liver disease complicating pregnancy. J Obstet Gynaecol India. 2009;59(5):427-31.

Jain R, Suri V, Chopra S, Chawla YK, Kohli KK. Obstetric cholestasis: outcome with active management. J Obstet Gynaecol Res. 2013;39(5):953-9.

Kumari M, Garg T, Mittal S. Intrahepatic cholestasis of pregnancy: a prospective study. J Obstet Gynaecol India. 2016;66(1):451-6.

Rathi C, Pipaliya N, Phadke A, Ingle M, Patel P, Sawant P. Spectrum of liver disorders in pregnancy from western India. Indian J Gastroenterol. 2015;34(3):216-24.

Haram K, Svendsen E, Abildgaard U. The HELLP syndrome: clinical issues and management. A review. BMC Pregnancy Childbirth. 2009;9:8.

Khuroo MS, Kamili S. Aetiology and prognostic factors in acute liver failure in India. J Viral Hepat. 2003;10(3):224-31.